ZK824190
CAS No. 2254001-81-3
ZK824190( —— )
Catalog No. M26523 CAS No. 2254001-81-3
ZK824190 is an orally available and selective inhibitor of urokinase plasminogen activator (uPA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 560 | In Stock |
|
| 5MG | 541 | In Stock |
|
| 10MG | 775 | In Stock |
|
| 25MG | 1188 | In Stock |
|
| 50MG | 1562 | In Stock |
|
| 100MG | 2111 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZK824190
-
NoteResearch use only, not for human use.
-
Brief DescriptionZK824190 is an orally available and selective inhibitor of urokinase plasminogen activator (uPA).
-
DescriptionZK824190 is an orally available and selective inhibitor of urokinase plasminogen activator (uPA). The IC50 values are 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively.(In Vivo):In rats with experimental autoimmune encephalomyelitis (EAE) model, ZK824190 (2 mg/kg; p.o.) exhibited a relatively high oral availability(F = 55%; Cmax= 0.64 g/mL and AUC = 2.2 h*g/mL) and a moderate half time of 2.8 h.
-
In Vitro——
-
In VivoZK824190 (2?mg/kg; PO) exhibits a relatively high oral availability and a moderate half time (T1/2=2.8 h). Animal Model:Rats with experimental autoimmune encephalomyelitis (EAE) model Dosage:2?mg/kg (Pharmacokinetic Analysis) Administration:PO Result:Oral availability F?=?55%; Cmax=?0.64?g/mL and AUC?=?2.2?h*g/mL; T1/2=2.8 h.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2254001-81-3
-
Formula Weight414.409
-
Molecular FormulaC22H20F2N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (603.28 mM)
-
SMILESCC[C@@H](Oc1nc(Oc2cccc(c2)-c2cccc(CN)c2)c(F)cc1F)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Talniflumate
Talniflumate is a calcium-activated chloride channel (hCLCA1/mCLCA3) blocker that reduces mucin synthesis and releases in animal models and cell culture.
-
1-Methoxycarbonyl-be...
1-Methoxycarbonyl-beta-carboline-N-oxide is a natural product for research related to life sciences.
-
Methyl retinoate
Methyl retinoate (Retinoic acid, methyl ester) induces aseptic inflammation at the site of administration in in vivo experiments, which causes an increase in the number of leukocytes in the blood and a decrease in the levels of red blood cells and Hb.Methyl retinoate promotes spontaneous leukemia.Methyl retinoate can be Used in the treatment of gastric hypertrophy and ulcers due to vitamin A deficiency.
Cart
sales@molnova.com